Abrams Royal Pharmacy

FDA inspection history in Dallas, Texas, 2013 to 2016

1
Close-out
1
Warning letter
1
Form 483

Every document, by year

  • Close-out
  • Warning letter
  • Form 483

2013: one Form 483; 2014: one warning letter; 2016: one close-out letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2013–16One Form 483, one warning letter and one close-out letter, at Dallas, Texas.

Cited most

Across all Abrams Royal Pharmacy observations on file

The complete Abrams Royal Pharmacy file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2016-09-28Close-out Close-out letter$99
2014-07-14Warning letter Warning letter$99
2013-12-20483 Form 483$99

Investigators on these documents

Elisa M. Fleming (1)Scott Ballard (1)

FEI number 1000138425 · most recent document Sep 28, 2016

About Abrams Royal Pharmacy

How many FDA Form 483s has Abrams Royal Pharmacy received?

FDA Intel has 1 Form 483 on file for Abrams Royal Pharmacy; the most recent is dated Dec 20, 2013.

When was Abrams Royal Pharmacy last inspected by FDA?

The most recent FDA inspection document on file for Abrams Royal Pharmacy is a Form 483 dated Dec 20, 2013, for the site in Dallas, Texas.

What did FDA cite at Abrams Royal Pharmacy?

The regulations cited most in the observations on file for Abrams Royal Pharmacy are 21 CFR 211.42(a) (Design and construction features), 3 times; 21 CFR 211.160(b) (General requirements), 2 times; 21 CFR 211.113(b) (Control of microbiological contamination), 1 time.

Has Abrams Royal Pharmacy received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Abrams Royal Pharmacy; the most recent is dated Jul 14, 2014.